Stage IB Pancreatic Cancer Completed Phase 2 Trials for Bevacizumab (DB00112)

Indication	Status	Phase
DBCOND0034490 (Stage IB Pancreatic Cancer)	Completed	2

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT00305877	Bevacizumab or Cetuximab And Gemcitabine Hydrochloride, Capecitabine, and Radiation Therapy in Treating Patients With Pacreatic Cancer That Has Been Completely Removed By Surgery	Treatment	Bevacizumab (DB00112) Capecitabine (DB01101) Cetuximab (DB00002) Gemcitabine (DB00441)